Bank of New York Mellon’s Milestone Scientific MLSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-29,138
Closed -$20.1K – 4258
2023
Q4
$20.1K Hold
29,138
– – ﹤0.01% 4238
2023
Q3
$26.8K Hold
29,138
– – ﹤0.01% 4222
2023
Q2
$25.4K Hold
29,138
– – ﹤0.01% 4264
2023
Q1
$26.2K Hold
29,138
– – ﹤0.01% 4278
2022
Q4
$14K Hold
29,138
– – ﹤0.01% 4391
2022
Q3
$23K Hold
29,138
– – ﹤0.01% 4437
2022
Q2
$27K Sell
29,138
-1,816
-6% -$1.85K ﹤0.01% 4461
2022
Q1
$47K Hold
30,954
– – ﹤0.01% 4531
2021
Q4
$64K Hold
30,954
– – ﹤0.01% 4464
2021
Q3
$58K Hold
30,954
– – ﹤0.01% 4412
2021
Q2
$76K Sell
30,954
-97,831
-76% -$237K ﹤0.01% 4259
2021
Q1
$460K Buy
128,785
+24,009
+23% +$82.3K ﹤0.01% 3732
2020
Q4
$222K Sell
104,776
-613
-0.6% -$1.08K ﹤0.01% 3945
2020
Q3
$146K Buy
105,389
+32,236
+44% +$56.2K ﹤0.01% 3912
2020
Q2
$142K Buy
+73,153
New +$134K ﹤0.01% 3868
2016
Q1
– Sell
-516,339
Closed -$1.21M – 4268
2015
Q4
$1.21M Buy
+516,339
New +$1.34M ﹤0.01% 3039

Other funds holding MLSS

Bank of New York Mellon's MLSS Position: Q1 2024 in Review

Bank of New York Mellon sold out of Milestone Scientific (MLSS) in Q1 2024, closing a stake of 29,138 shares — an estimated $20.1K sold.

Bank of New York Mellon first reported a position in MLSS in Q4 2015 and held it in 16 quarters. The position peaked at $1.21M in Q4 2015. 33 funds tracked by Wall St. Rank hold MLSS as of Q1 2024.

  • Bank of New York Mellon reported no remaining Milestone Scientific position as of Q1 2024 after selling out during the quarter.
  • Bank of New York Mellon sold 29,138 Milestone Scientific shares in Q1 2024, an estimated $20.1K.
  • Bank of New York Mellon first reported a position in Milestone Scientific in Q4 2015 and held it in 16 quarters.
  • Bank of New York Mellon's Milestone Scientific position peaked at $1.21M in Q4 2015.
  • 33 funds tracked by Wall St. Rank held Milestone Scientific as of Q1 2024.

Based on Bank of New York Mellon's 13F filing for Q1 2024, filed 25 Apr 2024.